Home Business Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 

by admin

The highest dose of Eli Lilly’s weekly injection helped patients with obesity or who are overweight lose 20.1% of their body weight on average at 48 weeks.Original Article

You may also like

Leave a Comment

14 − 5 =